Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: Immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1163-1166

  Caproni, M ^a   Torchia, D ^a   Volpi, W ^a   Frezzolini, A ^b   Schena, D ^c   Marzano, A ^d   Quaglino, P ^e   De Simone, C ^f   Parodi, A ^g   Fabbri, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

Author keywords

Collagenases; Erythema multiforme; Matrix metalloproteinase; Stevens Johnson syndrome toxic epidermal necrolysis; Stromelysin 3

Indexed keywords

GELATINASE A; GELATINASE B; STROMELYSIN 3;

CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHEMA MULTIFORME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; LICHEN PLANUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 11; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; STEVENS-JOHNSON SYNDROME;

EID: 42049097024     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08524.x     Document Type: Letter

References (10)

1. Caproni M, Torchia D, Schincaglia E et al. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br J Dermatol 2006 154 : 319 24.
2. Caproni M, Torchia D, Schincaglia E et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol 2006 155 : 722 8.
3. Paquet P, Nusgens BV, Pierard GE et al. Gelatinases in drug-induced toxic epidermal necrolysis. Eur J Clin Invest 1998 28 : 528 32.
4. Gaultier F, Ejeil AL, Igondjo-Tchen S et al. Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome. Arch Dermatol Res 2004 296 : 220 5.
5. Gunduz K, Demireli P, Inanir I et al. Expression of matrix metalloproteinases (MMP-2, MMP-3, and MMP-9) and fibronectin in lichen planus. J Cutan Pathol 2006 33 : 545 50.
6. Verma RP, Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 2007 15 : 2223 68.
7. Goetzl EJ, Bando MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996 156 : 1 4.
8. Gearing AJ, Beckett P, Christodoulov M et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinase. Nature 1994 370 : 555 7.
9. Delclaux C, Delacourt C, D'Ortho MP et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 1996 14 : 288 95.
10. Thewes M, Worret WI, Engst R et al. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders. Clin Exp Dermatol 1999 24 : 122 6.